Coding the Future

Gene Therapy Targeting Diseases Of Aging Prof George Church Interview Series Episode 2

gene therapy targeting diseases of Aging prof george ch
gene therapy targeting diseases of Aging prof george ch

Gene Therapy Targeting Diseases Of Aging Prof George Ch In this video professor church talks how he is using gene therapy to target aging and the benefits of gene therapy when compared to using small molecules. he. In this video professor church talks how he is using gene therapy to target aging and the benefits of gene therapy when compared to using small molecules. he talks about the study where his lab used a small number of gene therapies to target five or more diseases of aging and the follow up they are now doing. george church is the robert winthrop professor of genetics at harvard medical school.

gene therapy targeting diseases of Aging prof george ch
gene therapy targeting diseases of Aging prof george ch

Gene Therapy Targeting Diseases Of Aging Prof George Ch In this episode of longevity by design, our hosts, dr. gil blander and ashley reaver, ms, rd, cssd, are joined by dr. george church, professor of genetics at. Gene therapy targeting diseases of aging prof george church interview series episode 2 modern healthspan. subscribe. in this video professor church talks how he is using gene therapy to target aging and the benefits of gene therapy when compared to using small mol. George church is a noted geneticist, involved in a number of gene therapy projects that relate to aging in some way though largely through manipulation of metabolism to slow aging rather than by directly attacking the root causes of aging. gene therapy tends to lend itself to adjustment of cellular metabolism first and foremost, raising or. Prof. george church on cellular reprogramming and longevity. professor of genetics at harvard medical school, a veteran geroscientist, and a serial entrepreneur, george church hardly needs an introduction. while we are always happy to discuss the present and future of geroscience with him, this interview focuses on the two gene therapy papers.

Comments are closed.